Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study - Concepedia

Concepedia

Publication | Open Access

Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre study

DOI Full Paper Access

10

Citations

12

References

2024

Year

Chia‐Chi Lin, Giuseppe Curigliano, Armando Santoro, Dong‐Wan Kim, David Tai, F. Stephen Hodi, Sofie Wilgenhof, Toshihiko Doi, Catherine Sabatos-Peyton, Sebastian Szpakowski,

Abstract

NCT02608268.

References

	Year	Citations

Page 1